Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Clinical trial NCT02202395 · COMPLETED
Trial details
- NCT number
- NCT02202395
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-04-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.